Epsilon HealthcareASX:EPN Days Payable is 263.34 as of Dec. 2025, which is 31% above its 10-year median of 201.10. The stock has 4 warning signs investors should review. Among 920 Drug Manufacturers companies, Epsilon Healthcare ranks better than 89.89% on this metric.
The historical rank and industry rank for Epsilon Healthcare's Days Payable or its related term are showing as below:
ASX:EPN'
s Days Payable Range Over the Past 10 Years
Min: 61.37 Med: 201.1 Max: 640.61
Current: 265.32
During the past 9 years, Epsilon Healthcare's highest Days Payable was 640.61. The lowest was 61.37. And the median was 201.10.
ASX:EPN's Days Payable is ranked better than 89.89% of 920
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs ASX:EPN: 265.32
Epsilon Healthcare's Days Payable
declined
from Dec. 2024 (538.77) to Dec. 2025 (263.34).
It may suggest that Epsilon Healthcareaccelerated paying its suppliers.
Epsilon Healthcare Days Payable Related Terms
Epsilon Healthcare Days Payable Historical Data
* Premium members only.
The historical data trend for Epsilon Healthcare's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Epsilon Healthcare's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Epsilon Healthcare Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Epsilon Healthcare's Days Payable distribution charts can be found below:
* The bar in red indicates where Epsilon Healthcare's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Epsilon Healthcare's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Epsilon Healthcare (ASX:EPN) has a Days Payable of 263.34 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Epsilon Healthcare and its competitors. This is 31% above median its historical median of 201.10. Over the past decade, Epsilon Healthcare's Days Payable has ranged from 61.37 to 640.61. According to the industry distribution chart, Epsilon Healthcare ranks #93 out of 920 companies in the Drug Manufacturers industry, placing it in the top 10.1%.
Is Epsilon Healthcare's Days Payable too high?
Epsilon Healthcare's current Days Payable of 263.34 is 31% above median its 10-year median of 201.10. Over the past 10 years, this metric has ranged from a low of 61.37 to a high of 640.61. The Drug Manufacturers industry median Days Payable is 90.84. Epsilon Healthcare's value of 263.34 is 189.9% above this industry median. Based on the distribution chart, Epsilon Healthcare ranks #93 out of 920 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Epsilon Healthcare's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Epsilon Healthcare ranks #93 out of 920 companies for Days Payable. This places Epsilon Healthcare in the top 10% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.84. Epsilon Healthcare's value of 263.34 is 189.9% above this benchmark. Historically, Epsilon Healthcare's own Days Payable has ranged from 61.37 to 640.61 over the past decade. While the company's 10-year median is 201.10 vs. the industry median of 90.84, Epsilon Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Epsilon Healthcare's current Days Payable of 263.34 is 189.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Epsilon Healthcare and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Epsilon Healthcare's current Days Payable is 263.34, which is 31% above median its own 10-year median of 201.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epsilon Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Epsilon Healthcare (ASX:EPN) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.02 — trading 26.7% below its estimated fair value. The current Days Payable is 263.34, which is 31% above median its 10-year median of 201.10 and 189.9% above the Drug Manufacturers industry median of 90.84. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Epsilon Healthcare (ASX:EPN), the current Days Payable is 263.34 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Epsilon Healthcare Ltd is an Australian based, globally active healthcare organisation. It operates a diversified and vertically integrated portfolio of assets, including healthcare and clinics operation, pharmaceutical contract development and manufacturing operation & pharmacy services. The company offers end-to-end solutions across the healthcare spectrum: from product development and manufacturing to patient care. The company's three (3) main operating segments are: a. Contract Development and Manufacturing activities, b. Telehealth medical practice services; and c. Pharmacy services. The majority of revenue is derived from the Contract Development and Manufacturing activities segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EPN has been successfully added to your 